BARKLEY PMHNP DIAGNOSTIC READINESS TEST QUESTIONS AND ANSWERS ALREADY GRADED A+| 100%
VERIFIED SOLUTIONS………...
Core Domains:
Psychiatric Assessment and Differential Diagnosis
Psychopharmacology and Prescriptive Authority
Psychotherapy and Therapeutic Interventions
Neurobiology and Pathophysiology of Mental Illness
Ethical, Legal, and Regulatory Standards in Psychiatric Practice
Evidence-Based Practice and Clinical Guidelines
Crisis Intervention and Suicide Risk Assessment
Cultural Competency and Health Disparities
Substance Use Disorders and Addiction Medicine
Lifespan Development and Psychiatric Disorders
Introduction:
This Psychiatric-Mental Health Nurse Practitioner Diagnostic Readiness Test is a comprehensive assessment
designed to evaluate the candidate's clinical competence and readiness for certification examination. The exam
measures advanced diagnostic reasoning, pharmacologic knowledge, and the ability to apply evidence-based
guidelines in the care of patients with psychiatric and mental health disorders. The structure includes multiple-
,choice questions that test foundational theory, psychopharmacology, regulatory compliance, ethical decision-
making, and critical thinking. Each question emphasizes real-world application, challenging the test-taker to
synthesize information, prioritize interventions, and make sound clinical judgments. Success on this examination
indicates mastery of the core competencies required for safe, effective, and independent practice as a Psychiatric-
Mental Health Nurse Practitioner.
SECTION ONE: QUESTIONS 1–100
1. A 34-year-old female with a history of major depressive disorder presents with recurrent episodes of
depression characterized by increased appetite, hypersomnia, and leaden paralysis. Which of the following is
the most likely specifier for her diagnosis?
A. Melancholic features
B. Atypical features
C. Psychotic features
D. Seasonal pattern
🟢 B. Atypical features
🔴 RATIONALE: Atypical features of major depressive disorder include increased appetite, hypersomnia, leaden
paralysis, and mood reactivity. Melancholic features are characterized by anhedonia and lack of reactivity.
,2. A 48-year-old male with a history of bipolar I disorder is stabilized on lithium. He presents with a new
onset of tremor, ataxia, and confusion. His serum lithium level is 2.8 mEq/L. Which of the following is the
most appropriate next step in management?
A. Administer IV fluids and hold lithium
B. Administer sodium polystyrene sulfonate
C. Initiate hemodialysis
D. Administer activated charcoal
🟢 A. Administer IV fluids and hold lithium
🔴 RATIONALE: Lithium toxicity with a level of 2.8 mEq/L is moderate. The first step is to hold lithium and
administer IV fluids to enhance renal excretion. Hemodialysis is reserved for severe toxicity with levels > 3.5
mEq/L or severe symptoms.
3. A 26-year-old female presents with a first episode of psychosis characterized by auditory hallucinations,
delusions, and disorganized behavior. She has no prior psychiatric history. Which of the following is the most
appropriate initial treatment?
A. Haloperidol
B. Risperidone
C. Clozapine
D. Olanzapine
🟢 B. Risperidone
🔴 RATIONALE: For first-episode psychosis, an atypical antipsychotic such as risperidone is preferred due to its
, efficacy and favorable side effect profile. Clozapine is reserved for treatment-resistant schizophrenia.
4. A 42-year-old female with a history of generalized anxiety disorder is started on buspirone. Which of the
following statements about buspirone is correct?
A. It has a rapid onset of action
B. It is a benzodiazepine
C. It has no abuse potential
D. It acts on GABA receptors
🟢 C. It has no abuse potential
🔴 RATIONALE: Buspirone is a non-benzodiazepine anxiolytic that acts on serotonin receptors and has no
abuse potential. It has a delayed onset of action (2-4 weeks) and is not a controlled substance.
5. A 60-year-old male with a history of Parkinson's disease presents with visual hallucinations and paranoia.
He is on carbidopa-levodopa. Which of the following is the most appropriate next step in management?
A. Increase the dose of carbidopa-levodopa
B. Add quetiapine
C. Decrease the dose of carbidopa-levodopa
D. Add risperidone
VERIFIED SOLUTIONS………...
Core Domains:
Psychiatric Assessment and Differential Diagnosis
Psychopharmacology and Prescriptive Authority
Psychotherapy and Therapeutic Interventions
Neurobiology and Pathophysiology of Mental Illness
Ethical, Legal, and Regulatory Standards in Psychiatric Practice
Evidence-Based Practice and Clinical Guidelines
Crisis Intervention and Suicide Risk Assessment
Cultural Competency and Health Disparities
Substance Use Disorders and Addiction Medicine
Lifespan Development and Psychiatric Disorders
Introduction:
This Psychiatric-Mental Health Nurse Practitioner Diagnostic Readiness Test is a comprehensive assessment
designed to evaluate the candidate's clinical competence and readiness for certification examination. The exam
measures advanced diagnostic reasoning, pharmacologic knowledge, and the ability to apply evidence-based
guidelines in the care of patients with psychiatric and mental health disorders. The structure includes multiple-
,choice questions that test foundational theory, psychopharmacology, regulatory compliance, ethical decision-
making, and critical thinking. Each question emphasizes real-world application, challenging the test-taker to
synthesize information, prioritize interventions, and make sound clinical judgments. Success on this examination
indicates mastery of the core competencies required for safe, effective, and independent practice as a Psychiatric-
Mental Health Nurse Practitioner.
SECTION ONE: QUESTIONS 1–100
1. A 34-year-old female with a history of major depressive disorder presents with recurrent episodes of
depression characterized by increased appetite, hypersomnia, and leaden paralysis. Which of the following is
the most likely specifier for her diagnosis?
A. Melancholic features
B. Atypical features
C. Psychotic features
D. Seasonal pattern
🟢 B. Atypical features
🔴 RATIONALE: Atypical features of major depressive disorder include increased appetite, hypersomnia, leaden
paralysis, and mood reactivity. Melancholic features are characterized by anhedonia and lack of reactivity.
,2. A 48-year-old male with a history of bipolar I disorder is stabilized on lithium. He presents with a new
onset of tremor, ataxia, and confusion. His serum lithium level is 2.8 mEq/L. Which of the following is the
most appropriate next step in management?
A. Administer IV fluids and hold lithium
B. Administer sodium polystyrene sulfonate
C. Initiate hemodialysis
D. Administer activated charcoal
🟢 A. Administer IV fluids and hold lithium
🔴 RATIONALE: Lithium toxicity with a level of 2.8 mEq/L is moderate. The first step is to hold lithium and
administer IV fluids to enhance renal excretion. Hemodialysis is reserved for severe toxicity with levels > 3.5
mEq/L or severe symptoms.
3. A 26-year-old female presents with a first episode of psychosis characterized by auditory hallucinations,
delusions, and disorganized behavior. She has no prior psychiatric history. Which of the following is the most
appropriate initial treatment?
A. Haloperidol
B. Risperidone
C. Clozapine
D. Olanzapine
🟢 B. Risperidone
🔴 RATIONALE: For first-episode psychosis, an atypical antipsychotic such as risperidone is preferred due to its
, efficacy and favorable side effect profile. Clozapine is reserved for treatment-resistant schizophrenia.
4. A 42-year-old female with a history of generalized anxiety disorder is started on buspirone. Which of the
following statements about buspirone is correct?
A. It has a rapid onset of action
B. It is a benzodiazepine
C. It has no abuse potential
D. It acts on GABA receptors
🟢 C. It has no abuse potential
🔴 RATIONALE: Buspirone is a non-benzodiazepine anxiolytic that acts on serotonin receptors and has no
abuse potential. It has a delayed onset of action (2-4 weeks) and is not a controlled substance.
5. A 60-year-old male with a history of Parkinson's disease presents with visual hallucinations and paranoia.
He is on carbidopa-levodopa. Which of the following is the most appropriate next step in management?
A. Increase the dose of carbidopa-levodopa
B. Add quetiapine
C. Decrease the dose of carbidopa-levodopa
D. Add risperidone
